A share price of DENTSPLY Sirona Inc [XRAY] is currently trading at $19.72, down -1.45%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The XRAY shares have gain 3.35% over the last week, with a monthly amount glided 13.66%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
DENTSPLY Sirona Inc [NASDAQ: XRAY] stock has seen the most recent analyst activity on December 04, 2024, when Mizuho initiated its Neutral rating and assigned the stock a price target of $21. Previously, Leerink Partners downgraded its rating to Market Perform on November 07, 2024. On October 25, 2024, Needham reiterated its Buy rating and revised its price target to $29 on the stock. Needham reiterated its Buy rating but stick to its price target of $34 on August 20, 2024. Leerink Partners initiated its recommendation with a Outperform and recommended $42 as its price target on February 26, 2024. Needham started tracking with a Buy rating for this stock on November 16, 2023, and assigned it a price target of $35. In a note dated November 10, 2023, William Blair upgraded an Outperform rating on this stock.
DENTSPLY Sirona Inc experienced fluctuations in its stock price throughout the past year between $17.21 and $37.60. Currently, Wall Street analysts expect the stock to reach $29.5 within the next 12 months. DENTSPLY Sirona Inc [NASDAQ: XRAY] shares were valued at $19.72 at the most recent close of the market. An investor can expect a potential return of 49.59% based on the average XRAY price forecast.
Analyzing the XRAY fundamentals
Trailing Twelve Months sales for DENTSPLY Sirona Inc [NASDAQ:XRAY] were 3.90B which represents 0.42% growth. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.06, Equity is -0.14 and Total Capital is -0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.89.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 19.46 points at the first support level, and at 19.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 20.08, and for the 2nd resistance point, it is at 20.43.
Ratios To Look Out For
To put it in perspective, the Current Ratio for DENTSPLY Sirona Inc [NASDAQ:XRAY] is 1.25. In addition, the Quick Ratio stands at 0.84 and the Cash Ratio stands at 0.19. Considering the valuation of this stock, the price to sales ratio is 0.99, the price to book ratio is 1.57.
Transactions by insiders
Recent insider trading involved LUCIER GREGORY T, Director, that happened on Nov 18 ’24 when 5000.0 shares were purchased. Director, LUCIER GREGORY T completed a deal on Nov 15 ’24 to buy 1000.0 shares. Meanwhile, President, CEO & Member of BOD Campion Simon D bought 11306.0 shares on Nov 12 ’24.
